JAYPIRCA
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for JAYPIRCA, covering 2023-01-27 to 2026-01-28. Get the full timeline:
Most recent: EMA Authorised: Jaypirca (pirtobrutinib) — Eli Lilly Nederland B.V.